Amarin | AMRN - 부채에 대한이자 비용

주가
14.31
매일 변경
-0.28 -1.92%
매월
-2.52%
매년
37.20%
Q2 예상
13.88




부채에 대한이자 비용 변화 날짜
AbbVie USD 740M 40M 2025-06
Alnylam Pharmaceuticals USD 129.34M 84.94M 2025-12
Amarin USD 3K 5K 2024-12
AstraZeneca USD 484M 181M 2025-12
BioCryst Pharmaceuticals USD 14.14M 5.53M 2025-12
DBV Technologies USD 461K 323.71K 2025-03
Esperion Therapeutics USD 22.64M 585K 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
Halozyme Therapeutics USD 4.91M 615K 2025-12
Heron Therapeutics USD 600K 100K 2024-12
Ionis Pharmaceuticals USD 18M 0 2025-12
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 304M 23M 2025-12